Novartis has announced that the European Commission has approved Gilenya (fingolimod) as a treatment for children and adolescents (10–17 years) with relapsing-remitting forms of multiple sclerosis (RRMS). / read more /
NICE has recommended the use of regorafenib as a treatment for NHS patients with advanced liver cancer, following consideration of a new commercial arrangement. / read more /
Evonik sets new standard for enteric coatings:
EUDRAGIT® FL 30 D-55 is an advanced, new combination polymer solution for enteric coatings that integrates the respective benefits of two existing, well-accepted monographs. It is highly flexible for plasticizer-free formulations, and can be sprayed with a smooth, fast and no-stick process. As a single product, preparation times can be reduced by up to 70%. To request a product sample, email healthcare@evonik.com Learn more
GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion (EUR 4.5 billion) / read more /
By adapting techniques from other sciences–and exploring better tools for biologics drug development—researchers are addressing challenges of protein characterization. / read more /
Rather than isolating the user in a virtual world, mixed reality allows contextualized data to be shared in real time, improving assays, standard operating procedures, workflows, and overall tech transfer. / read more /
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation— as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.
